Two groups of researchers from Children’s Hospital Boston, Brigham and Women’s Hospital, and the Harvard Stem Cell Institute (HSCI) -– presenting multiple lines of evidence from zebrafish, mice and mouse embryonic stem cells -– provide an intriguing answer: A beating heart and blood flow are necessary for development of the blood system, which relies on mechanical stresses to cue its formation.
Their studies, published online by the journals Cell and Nature, respectively, on May 13, together offer clues that may help in treating blood diseases such as leukemia, immune deficiency and sickle cell anemia, suggesting new ways scientists can make the types of blood cells a patient needs. This would help patients who require marrow or cord blood transplants, who do not have a perfect donor match.
One team, led by Leonard Zon, MD, of the Division of Hematology/Oncology at Children’s and Director of its Stem Cell research program, used zebrafish, whose transparent embryos allow direct observation of embryonic development. Publishing in Cell, Zon and colleagues discovered that compounds that modulate blood flow had a potent impact on the expression of a master regulator of blood formation, known as Runx1, which is also a recognized marker for the blood stem cells that give rise to all the cell types in the blood system.
Confirming this observation, a strain of mutant embryos that lacked a heartbeat and blood circulation exhibited severely reduced numbers of blood stem cells. Further work showed that nitric oxide, whose production is increased in the presence of blood flow, is the key biochemical regulator: Increasing nitric oxide production restored blood stem cell production in the mutant fish embryos, while inhibiting nitric oxide production led to reduced stem cell number.
Zon and colleagues went on to demonstrate that nitric oxide production was coupled to the initiation of blood stem cell formation across vertebrate species. Suppression of nitric oxide production in mice, by either genetic or chemical means, similarly reduced the number of functional Runx1-expressing blood stem cells.
“Nitric oxide appears to be a critical signal to start the process of blood stem cell production,” says Zon, who is also affiliated with the HSCI. “This finding connects the change in blood flow with the production of new blood cells.”
The second team, publishing in Nature, was led by George Q. Daley, MD, PhD, director of the Stem Cell Transplantation Program at Children’s Hospital Boston, and Guillermo García-Cardeña, director of the Laboratory for Systems Biology of the Center for Excellence in Vascular Biology at Brigham and Women's Hospital, along with scientists from the Indiana University School of Medicine. Intrigued by the appearance of blood progenitors in the wall of the developing aorta soon after the heart starts beating, they investigated the effects of mechanical stimulation on blood formation in cultured mouse embryonic stem cells.
They showed that shear stress –- the frictional force of fluid flow on the surface of cells lining the embryonic aorta –- increases the expression of master regulators of blood formation, including Runx1, and of genetic markers found in blood stem cells. Shear stress also increased formation of colonies of progenitor cells that give rise to specific lineages of blood cells (red cells, lymphocytes, etc.). These findings demonstrate that biomechanical forces promote blood formation.
Daley, García-Cardeña and colleagues also studied mouse embryos with a mutation that prevented initiation of the heartbeat. These embryos had a sharp reduction in progenitor blood cell colonies, along with reduced expression of genetic markers of blood stem cells. When specific cells from the mutant embryos were exposed in vitro to shear stress, markers of blood stem cells and numbers of blood cell colonies were restored.
Finally, the team showed that when nitric oxide production was inhibited, in both cell cultures and live mouse embryos, the effects of shear stress on blood progenitor colony formation were reduced.
“In learning how the heartbeat stimulates blood formation in embryos, we’ve taken a leap forward in understanding how to direct blood formation from embryonic stem cells in the petri dish,” says Daley, who is also affiliated with the HSCI.
“These observations reveal an unexpected role for biomechanical forces in embryonic development,” adds García-Cardeña. “Our work highlights a critical link between the formation of the cardiovascular and hematopoietic systems.”
The authors of the two papers speculate that drugs that mimic the effects of embryonic blood flow on blood precursor cells, or molecules involved in nitric oxide signaling, might be therapeutically beneficial for patients with blood diseases. For example, nitric oxide could be used to grow and expand blood stem cells either in the culture dish or in patients after transplantation.
Trista North, PhD, and Wolfram Goessling, MD, PhD, now principal faculty at HSCI and assistant professors at Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital, respectively, were first authors on the Cell paper. Luigi Adamo, MD, of Brigham and Women’s Hospital and Olaia Naveiras, MD, PhD of Children’s Hospital Boston and Brigham and Women’s Hospital were first authors on the Nature paper. The studies were supported by the National Institutes of Health, the NIH Director’s Pioneer Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the Howard Hughes Medical Institute (Zon and Daley are HHMI investigators).
Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 12 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School.
Brigham and Women’s Hospital is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty.
The Harvard Stem Cell Institute is a scientific collaborative established to fulfill the promise of stem cell biology as the basis for cures and treatments for a wide range of chronic medical conditions.
Bess Andrews | Newswise Science News
Further reports about: > HSCI > Heartbeat > Nature Immunology > Runx1 > Stem cell innovation > blood cell > blood diseases > blood flow > blood stem cells > blood system > cell death > embryonic development > embryonic stem > embryonic stem cell > genetic marker > mouse embryo > nitric oxide > stem cells > synthetic biology
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences